ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Losing Stock Guy: Why He Went Wrong
By Kevin Matras

Quote:

Search for Ticker

Free Membership

Search:

ARTC: Arthrocare Corp - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

ARTHROCARE CORP (OTC)
ARTC	21.00	-0.50	(-2.33%)	Vol. 10,843	13:21 ET

ArthroCare Corp. is a medical device company that develops, manufactures and markets products based on its patented Coblation technology. The company's soft-tissue surgery systems consist of a controller unit and an assortment of disposable devices that are specialized for specific types of surgery. The company's strategy includes applying its patented Coblation technology to a range of soft-tissue surgical markets, including arthroscopic surgery, cosmetic surgery, nose and throat surgery, spinal surgery, neurosurgery, general surgery, and cardiology applications.

General Information

ARTHROCARE CORP

7500 Rialto Boulevard, Building Two Suite 100 Austin, TX 78735 Phone: 512 391-3900 Fax: 512-391-3901 Web: www.arthrocare.com Email: investor-relations@arthrocare.com

Industry	MED INSTRUMENTS
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	-

Price and Volume Information

Zacks Rank
Yesterday's Close	21.50
52 Week High	22.40
52 Week Low	2.89
Beta	2.19
20 Day Moving Average	131,639.70
Target Price Consensus	10.22

% Price Change
4 Week	12.37
12 Week	23.86
YTD	357.02

% Price Change Relative to S&P 500
4 Week	11.16
12 Week	16.78
YTD	278.24

Share Information
Shares Outstanding (millions)	26.63
Market Capitalization (millions)	580.47
Short Ratio	0.00
Last Split Date	07/05/2000

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	N/A
Current Year EPS Consensus Estimate	0.78
Estimated Long-Term EPS Growth Rate	-
Next EPS Report Date	-

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	3.00
30 Days Ago	4.00
60 Days Ago	4.00
90 Days Ago	4.00

Fundamental Ratios

P/E
Current FY Estimate:	27.95
Trailing 12 Months:	-
PEG Ratio	-

EPS Growth
vs. Previous Year	-%
vs. Previous Quarter	-%

Sales Growth
vs. Previous Year	-13.45%
vs. Previous Quarter:	-%

Price Ratios
Price/Book	2.44
Price/Cash Flow	80.73
Price / Sales	-

ROE
09/30/09	-
06/30/09	-
03/31/09	-

ROA
09/30/09	-
06/30/09	-
03/31/09	-

Current Ratio
09/30/09	-
06/30/09	-
03/31/09	1.31

Quick Ratio
09/30/09	-
06/30/09	-
03/31/09	0.87

Operating Margin
09/30/09	-
06/30/09	-
03/31/09	-

Net Margin
09/30/09	-
06/30/09	-
03/31/09	-

Pre-Tax Margin
09/30/09	-
06/30/09	-
03/31/09	-

Book Value
09/30/09	-
06/30/09	-
03/31/09	8.95

Inventory Turnover
09/30/09	-
06/30/09	-
03/31/09	-

Debt-to-Equity
09/30/09	-
06/30/09	-
03/31/09	0.00

Debt to Capital
09/30/09	-
06/30/09	-
03/31/09	0.00


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research